ASHP Foundation Announces 2019 Literature Award Recipients
Vincent H. Tam Receives ASHP Foundation Literature Award for Sustained Contributions
The ASHP Foundation has selected the recipients of the 2019 Literature Awards. The Literature Awards Program was created to stimulate research and innovation by recognizing pharmacists who have made significant contributions to biomedical literature. Five unique categories make up these annual awards including the prestigious Literature Award for Sustained Contributions which has been awarded to Vincent H. Tam, Pharm.D., FIDA, BCPS, for his internationally recognized research in antimicrobial pharmacokinetics, pharmacodynamics, and antimicrobial optimization.
Tam is a tenured professor at the University of Houston College of Pharmacy and an associate adjunct professor at the University of Houston Cullen College of Engineering. Tam also serves on the Editorial Board of the Antimicrobial Agents and Chemotherapy, and Associate Editor of the Journal of Global Antimicrobial Resistance. Since 2002, Tam has received research support totaling more than $9 million. He is the author of over 160 peer-reviewed articles and has served as an ad hoc reviewer for more than 25 other articles.
Tam’s work has been honored with awards such as the Impact Paper in Pharmacotherapy Award from the Society of Infectious Diseases Pharmacists in 2014. Findings from his studies have provided vital clinical evidence to support antimicrobial treatment based on pharmacokinetics and pharmacodynamics. Such evidence has sparked discussions among clinicians and researchers on an evidence-based approach to setting susceptibility interpretive criteria.
“My laboratory is devoted to studying the quantitative relationship between antimicrobial agent exposure and clinical, microbiological, and toxicity outcomes,” said Tam. “We have and will continue to collaborate with infectious diseases clinicians and researchers to determine the optimal exposure of relevant antimicrobial agents in vivo, facilitate translational studies, and develop means to improve patient care.”
This awards program includes four other categories:
Drug Therapy Research Award
“Association of Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists with Asthma Control in Patients with Uncontrolled, Persistent Asthma: A Systematic Review and Meta-Analysis.”
Diana M. Sobieraj, Pharm.D., William L. Baker, Pharm.D., Elaine Nguyen, Pharm.D., M.P.H., Erin R. Weeda, Pharm.D., Craig I. Coleman, Pharm.D., C. Michael White, Pharm.D., Stephen C. Lazarus, M.D., Kathryn V. Blake, Pharm.D., Jason E. Lang, M.D.
JAMA. 2018; 319: 1473-84.
Innovation in Pharmacy Practice Award
“Impact of Requiring Re-Authorization of Restricted Antibiotics on Day 3 of Therapy.”
Khalid Eljaaly, Pharm.D., BCPS, BCIDP, David E. Nix, Pharm.D., BCPS (AQ‐ID), FCCP, Salwa Elarabi, BSc, BCPS, Samah Alshehri, Pharm.D., M.S., BCPS.
J Antimicrob Chemotherapy. 2018; 73:527-30.
Pharmacy Practice Award
“Impact of a Pharmacist–Physician Collaborative Care Model on Patient Outcomes and Health Services Utilization.”
Gary Matzke, Pharm.D., Karen J. Williams, Pharm.D., Leticia R. Moczygemba, Pharm.D., Ph.D., William T. Lee, B.S.Pharm., M.P.A., Michael J. Czar, B.S.Pharm., Ph.D.
Am J Health Syst Pharm. 2018 Jul 15;75(14):1039-1047.
Student Research Award
“Pharmacotherapy-Induced Hepatitis B Reactivation Among Patients with Prior Functional Cure: A Systematic Review.”
Rhiannon Garcia, Pharm.D., Kellie Goodlet, Pharm.D., Brandelyn Doering, Pharm.D., Michael Nailor, Pharm.D.
Annals of Pharmacotherapy. 2018;53(3):294-310.
About the ASHP Foundation
The ASHP Foundation was established in 1968 by ASHP as a nonprofit, tax-exempt organization. As the philanthropic arm of ASHP, the Foundation shares ASHP’s vision that medication use will be optimal, safe, and effective for all people all of the time. Our mission is to support ASHP by advancing the professional practice of pharmacists and the pharmacy workforce by funding research and education that improves health outcomes through optimal, safe, and effective medication use.
Barbara Nussbaum, Vice President for Research & Education
Shelby M. Giles